Atlas FDA

Boston Orthokeratology (oprifocon A) Shaping Lens for Overnight Wear for Bausch + Lomb Vision Shaping Treatment

FDA premarket approval P010062/S013 · decided 2024-07-18

Approval details

PMA number
P010062
Supplement
S013
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Boston Orthokeratology (oprifocon A) Shaping Lens for Overnight Wear for Bausch + Lomb Vision Shaping Treatment
Generic name
Lens, contact, orthokeratology, overnight
Applicant
Bausch & Lomb
Date received
2024-06-21
Decision date
2024-07-18
Days to decision
27 days
Decision code
OK30
Product code
NUU
Advisory committee
Ophthalmic
Expedited review
No
Location
Rochester, NY
Statement
transfer of existing monomer synthesis operations for two monomers from the same supplier to a different manufacturing facility in Riegelwood, NC

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stellaris Elite vision enhancement system (K170052)Bausch+Lomb2017-04-19
Stellaris Elite Vision Enhancement System (K162342)Bausch+Lomb2017-03-24
STELLARIS PC VISION ENHANCEMENT SYSTEM (K133486)Bausch & Lomb2014-03-12
STELLARIS VISION ENHANCEMENT SYSTEM (K133242)Bausch & Lomb2014-02-14
BAUSCH & LOMB INJECTOR SYSTEM (K131958)Bausch & Lomb2014-01-09
BAUSCH + LUMB, VIS100 INJECTOR SYSTEM (K133146)Bausch & Lomb2014-01-03
EASY-LOAD LENS DELIVERY SYSTEM (K132481)Bausch & Lomb2013-12-27
CRYSTALSERT DELIVERY SYSTEM (K132593)Bausch & Lomb2013-09-17